Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease

9 Mar 2024

Abstract excerpt

BACKGROUND: Pulmonary toxicity has been associated with drug use. This is often not recognized in clinical practice, and underestimated. OBJECTIVE: We aimed to establish whether polymorphisms in certain genes corresponding with a metabolic pathway of drug(s) used are associated with pulmonary toxicity in patients with suspected drug-induced interstitial lung disease (DI-ILD). METHODS: This retrospective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38460070
DOI: 10.1007/s40264-024-01400-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung DiseasePMID 38460070Read ↗

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.Semantic proximity Read ↗

Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.Semantic proximity Read ↗

Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers.Semantic proximity Read ↗

Epigenetic modifications in idiosyncratic drug-induced liver injury: A systematic reviewSemantic proximity Read ↗

Drug-Induced Liver Injury: Insights from Genetic StudiesSemantic proximity Read ↗

Pharmacogenetics and interstitial lung disease.Semantic proximity Read ↗

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.Semantic proximity Read ↗

Pharmacogenomics in drug induced liver injury.Semantic proximity Read ↗

Risk Factors for Idiosyncratic Drug-Induced Liver InjurySemantic proximity Read ↗

Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genesSemantic proximity Read ↗

Assessment of Drugs Toxicity and Associated Biomarker Genes Using Hierarchical ClusteringSemantic proximity Read ↗

Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic PerspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.